Literature DB >> 21523383

The paradox of low BNP levels in obesity.

Aldo Clerico1, Alberto Giannoni, Simona Vittorini, Michele Emdin.   

Abstract

The aim of this review is to analyze in detail some possible pathophysiological mechanisms linking obesity and cardiac endocrine function, in order to try to explain the negative association previously observed between BMI and BNP values in both healthy subjects and patients with cardiovascular diseases. In particular, we discuss the hypothesis that the response of the cardiac endocrine system is the integrated resultant of several and contrasting physiological and pathological interactions, including the effects of peptide and steroid hormones, cytokines, cardiovascular hemodynamics, clinical conditions, and pharmacological treatment. Several studies suggested that gonadal function regulates both body fat distribution and cardiac endocrine function. Visceral fat expansion can increase the clearance of active natriuretic peptides by means of an increased expression of clearance receptors on adipocytes, and in this way, it may contribute to decrease the activity of the cardiac endocrine system. Moreover, obesity is associated with ectopic lipid deposition even in the heart, which may directly exert a lipotoxic effect on the myocardium by secreting in loco several cytokines and adipokines. Obese subjects are frequently treated for hypertension and coronary artery disease. Pharmacological treatment reduces plasma level of cardiac natriuretic peptides, and this effect may explain almost in part the lower BNP levels of some asymptomatic subjects with increased BMI values. At present time, it is not possible to give a unique and definitive answer to the crucial question concerning the inverse relationship between the amount of visceral fat distribution and BNP levels. Our explanation for these unsatisfactory results is that the cardiac endocrine response is always the integrated resultant of several pathophysiological interactions. However, only few variables can be studied together; as a result, it is not possible to perform a complete evaluation of pathophysiological mechanisms under study. We are still not able to well integrate these multiple information together; therefore, we should learn to do it.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21523383     DOI: 10.1007/s10741-011-9249-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  164 in total

Review 1.  Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications.

Authors:  Hugo Ramos; Adolfo J de Bold
Journal:  Heart Fail Clin       Date:  2006-07       Impact factor: 3.179

2.  Scale-free networks: a decade and beyond.

Authors:  Albert-László Barabási
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

3.  Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.

Authors:  Eduardo Mascareno; Daniel Beckles; Manya Dhar-Mascareno; M A Q Siddiqui
Journal:  Vascul Pharmacol       Date:  2009-06-26       Impact factor: 5.773

4.  Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

Authors:  David A Morrow; James A de Lemos; Marc S Sabatine; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

5.  Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.

Authors:  S Maffei; S Del Ry; C Prontera; A Clerico
Journal:  Clin Sci (Lond)       Date:  2001-11       Impact factor: 6.124

6.  Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study.

Authors:  Takako Sugisawa; Ichiro Kishimoto; Yoshihiro Kokubo; Hisashi Makino; Yoshihiro Miyamoto; Yasunao Yoshimasa
Journal:  Endocr J       Date:  2010-06-01       Impact factor: 2.349

Review 7.  Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

Authors:  Alisdair D S Ryding; Saurabh Kumar; Angela M Worthington; David Burgess
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 8.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

Authors:  G Glazer
Journal:  Arch Intern Med       Date:  1991-10

Review 9.  Estrogens and glucocorticoid hormones in adipose tissue metabolism.

Authors:  Cecilia Mattsson; Tommy Olsson
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway.

Authors:  Benedetta Mattioli; Luciana Giordani; Maria Giovanna Quaranta; Marina Viora
Journal:  FEBS Lett       Date:  2009-02-28       Impact factor: 4.124

View more
  42 in total

1.  Expanding the role of cardiac biomarkers--natriuretic peptides and troponins--further in pre-Stage A.

Authors:  Yoshihiko Seino; Toshiaki Otsuka
Journal:  Hypertens Res       Date:  2014-09-25       Impact factor: 3.872

Review 2.  Coordinate control of adipose 'browning' and energy expenditure by β-adrenergic and natriuretic peptide signalling.

Authors:  S Collins; R Sarzani; M Bordicchia
Journal:  Int J Obes Suppl       Date:  2014-07-08

Review 3.  The Initial Evaluation and Management of a Patient with Heart Failure.

Authors:  Jamael Hoosain; Jabar Whittier; Farhan Hasni; Shelley Hankins
Journal:  Curr Cardiol Rep       Date:  2017-09-06       Impact factor: 2.931

4.  Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study.

Authors:  Gabriela Querejeta Roca; Susan Redline; Naresh Punjabi; Brian Claggett; Christie M Ballantyne; Scott D Solomon; Amil M Shah
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

5.  Should we target obesity in advanced heart failure?

Authors:  Amanda R Vest; James B Young
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

6.  Preoperative B-type natriuretic peptide levels are associated with outcome after total cavopulmonary connection (Fontan).

Authors:  Monique Radman; Roberta L Keller; Peter Oishi; Sanjeev A Datar; Kari Wellnitz; Anthony Azakie; Frank Hanley; Danton Char; Jong-Hau Hsu; Rambod Amrinovin; Ian Adatia; Jeffrey R Fineman
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-27       Impact factor: 5.209

7.  Adiponectin is independently associated with NT-proBNP: The Multi-Ethnic Study of Atherosclerosis.

Authors:  M A Allison; M H Criqui; A S Maisel; L B Daniels; C K Roberts; J F Polak; M Cushman
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-04-25       Impact factor: 4.222

8.  The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR).

Authors:  Monique Radman; Ricardo Mack; Joaquin Barnoya; Aldo Castañeda; Monica Rosales; Anthony Azakie; Nilesh Mehta; Roberta Keller; Sanjeev Datar; Peter Oishi; Jeffrey Fineman
Journal:  J Thorac Cardiovasc Surg       Date:  2013-04-09       Impact factor: 5.209

9.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

10.  The relationship between leptin and ventilatory control in heart failure.

Authors:  Ivan Cundrle; Virend K Somers; Prachi Singh; Bruce D Johnson; Christopher G Scott; Lyle J Olson
Journal:  J Card Fail       Date:  2013-10-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.